As GINA is Signed Into Law, Most Predict Great Gains, But Some See Shortcomings, Others Find a Mixed Bag
By John T. Aquino,
The Bureau of National Affairs
| 06. 05. 2008
[Quotes CGS's Marcy Darnovsky]
President Bush May 21 signed into law the Genetic Information
Nondiscrimination Act, which prohibits employers, health plans, and
insurers from discriminating against individuals on the basis of
genetic information. The new law was applauded by lawmakers of both
parties and by health-related groups. After the signing, however, some
individuals and organizations, while acknowledging up-front benefits,
began to suggest that, long term, the new law might lead to loss of
privacy and threaten biopharmaceutical research and intellectual
property. Others discounted those fears, predicting the industries
will be strengthened not harmed.
The Genetic Information Nondiscrimination Act (GINA), which was
introduced in Congress six times in various forms over the last 12
years and passed twice by the Senate but not by the House of
Representatives, was approved unanimously by the Senate April 24 and
on a vote of 414-1 by the House May 1 (2 LSLR 373, 5/9/08). The new
law (Pub. L. No. 110-233) aims to eliminate any fear of discrimination
by those who undergo genetic testing and thus encourage people to have
these potentially beneficial tests. The law amends the...
Related Articles
By Jessica Mouzo, El País | 10.03.2025
DNA is the molecule of life: this double-helix structure, present in every cell in the body and organized into fragments called genes, stores the instructions for making organisms function. It is a highly precise biological machine, but sometimes it breaks...
By Katherine Bourzac, Nature | 09.25.2025
A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type of DNA analysis...
By Claire Robinson, GMWatch | 09.29.2025
According to an article on BBC News, the Quadram Institute in Norwich is recruiting 76 people with low vitamin D to take part in the ViTaL-D Study, where some participants will eat soup containing tomatoes that have been genetically...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...